logo-loader
CSE:INNO OTCQB:INNPF

InnoCan Pharma Corp

Receive alerts
Market:
CSE
Price
0.31 CAD
Day Change
-3.13%
Market Cap:
$85.55 m
52 weeks high
0.52
52 weeks low
0.18

In brief

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms containing CBD.

The company and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the Covid-19 Corona Virus using CBD.

CBD-loaded exosomes hold the potential to help in the recovery of infected lung cells.

This product, which is expected to be administered by inhalation, will be tested against a variety of lung infections.